NCT03942029View on ClinicalTrials.gov

A Drug Interaction Study of LY3154207 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 21, 2019

Primary Completion Date

December 28, 2019

Study Completion Date

December 28, 2019

Conditions
Healthy
Interventions
DRUG

LY3154207 Capsule

Administered orally as capsule

DRUG

LY3154207 Tablet

Administered orally as tablet

DRUG

Placebo

Administered orally as tablet

DRUG

Fluconazole Tablet

Administered orally as tablet

Trial Locations (1)

32117

Covance Clinical Research Inc, Daytona Beach

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03942029 - A Drug Interaction Study of LY3154207 in Healthy Participants | Biotech Hunter | Biotech Hunter